Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational plozasiran for the ...

OPUVIZ™ is one of the first wave aflibercept biosimilars in EuropeOPUVIZ is the second European Commission (EC)-approved ophthalmology biosimilar under Samsung Bioepis and Biogen’s partnershipEC ...

The euro’s recent weakness against the dollar hasn’t stabilized, based on the weekly chart, UOB Global Economics & Markets ...

What a disgraceful attitude. He should be pleased people even come in his door. As a long time resident in Spain, I have been appalled at the cost of food in the UK. My partner, Amy, and myself ...